Viewing Study NCT06115902


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:35 AM
Study NCT ID: NCT06115902
Status: RECRUITING
Last Update Posted: 2023-11-29
First Post: 2023-10-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module